Scancell Holdings PLC. (SCNLF)

[fightfear]

The CEO has said that the first deal he expects to make is for a product from Scancell's Moditope platform. He also said on Investor Day that he doesn't intend to wait for any further development of Moditope before doing a deal.

If you listen to the Webconference posted on Scancell's website he also says about Moditope - "We're getting already significant interest from pharmaceutical companies, even at this early stage and with this particular platform we think its realistic to expect to do some licensing deals in the short to medium term."

Then there is the Sunday Times article where the CEO says the following about what he expects to follow with SCIB1 after publishing encouraging data last month - “We are looking at 2014 as the year we consummate a relationship or a deal to take this forward.”

(borrowed from LSE)


I don't think we'll have to wait long for those things to materialize. As soon as we get a licencing deal the share price will undoubtedly reflect that. Note that with Moditope patent application published, Scancell can now do licencing deals on both platforms (Immunobody and on Moditope).
It's also interesting to note that Inovio had a similar mcap before their deal with Roche, and has grown 800% since. You have a rare opportunity here to buy into a similar company before a deal is struck, which is pretty much guaranteed to happen BTW. And if you look at Scancell's results you'll see that they are significantly better than those of Inovio.